Get the latest news and blog posts from APCI, including press releases and articles about advocacy actions, industry happenings, clinical pharmacy information, independent pharmacy operations, and much more.
Co-op calls House passage of the 'Lower Costs, More Transparency' Act a strong step toward curbing PBM abuses while urging further federal reform.
APCI and Transparency-Rx join forces on Capitol Hill to push for bipartisan PBM reforms aimed at increasing transparency, accountability, and drug affordability.
APCI urges the DOJ to block Optum’s acquisition of Amedisys, warning that deeper insurer-PBM integration threatens competition, patient choice, and the integrity of care.
Bessemer, AL (Sept. 19) – The country’s largest pharmacy benefit managers (PBMs) are setting drug prices for patients at the pharmacy counter, and they are literally all over the map,… Read More »
APCI urges federal regulators to crack down on PBM-insurer consolidation, calling for stronger merger scrutiny to protect competition, patient access, and fair drug pricing.
BESSEMER, Ala. (May 24, 2023) – In a letter sent to one of the largest investors in America’s Big Three pharmacy benefit manager companies (PBMs), American Pharmacy Cooperative, Inc. (APCI)… Read More »
APCI endorses bipartisan legislation to end PBM spread pricing in Medicaid, calling it a critical step toward transparency, fair reimbursement, and lower costs for patients and taxpayers.
APCI’s “Choice Member Campaign” earns a prestigious MarCom Gold Award, recognizing a high-impact digital effort promoting top-performing independent pharmacies.
BESSEMER, Ala. (Sept. 20) – A judge’s decision to allow the merger between UnitedHealth Group and Change Healthcare to move forward is likely to prove detrimental to patients, providers, and… Read More »
APCI warns that while Congress’s drug pricing proposals make progress, they fall short by failing to address the root problem: anti-competitive PBM practices driving costs and limiting patient access.